These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8098317)

  • 1. Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia.
    Kitagawa M; Kamiyama R; Kasuga T
    Hum Pathol; 1993 Apr; 24(4):359-63. PubMed ID: 8098317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
    Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
    Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
    Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
    Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages. Immunohistochemical and morphometric study including reactive (inflammatory) myelitis, secondary aplastic anemia, AIDS, myelodysplastic syndromes and primary (idiopathic) osteomyelofibrosis.
    Titius BR; Thiele J; Schaefer H; Kreipe H; Fischer R
    Acta Haematol; 1994; 91(3):144-9. PubMed ID: 7522384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
    Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
    Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to Acquired and Inherited Bone Marrow Failure.
    Sieff CA
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
    Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
    Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocellular myelodysplastic syndromes (MDS): new proposals.
    Tuzuner N; Cox C; Rowe JM; Watrous D; Bennett JM
    Br J Haematol; 1995 Nov; 91(3):612-7. PubMed ID: 8555063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia.
    Kitagawa M; Kamiyama R; Takemura T; Kasuga T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(1):47-53. PubMed ID: 2567549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
    Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
    Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory anemia and the myelodysplastic syndromes.
    Lawrence LW
    Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.
    Schemenau J; Baldus S; Anlauf M; Reinecke P; Braunstein S; Blum S; Nachtkamp K; Neukirchen J; Strup C; Aul C; Haas R; Gattermann N; Germing U
    Eur J Haematol; 2015 Sep; 95(3):181-9. PubMed ID: 25600827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia.
    Koike M; Ishiyama T; Tomoyasu S; Tsuruoka N
    Leuk Res; 1995 Sep; 19(9):639-44. PubMed ID: 7564474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance.
    Alexandrakis MG; Passam FH; Dambaki K; Passam AM; Nalbanti F; Stathopoulos ES; Kyriakou DS
    Eur J Histochem; 2005; 49(1):27-32. PubMed ID: 15823791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial morphologic observation of bone marrow in aplastic anemia in children.
    Bessho F; Imashuku S; Hibi S; Tsuchida M; Nakahata T; Miyazaki S; Kojima S; Tsukimoto I; Hamajima N;
    Int J Hematol; 2005 Jun; 81(5):400-4. PubMed ID: 16158820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
    Barrett J; Saunthararajah Y; Molldrem J
    Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.